Koyfin Home > Directory > Health Care > Nymox Pharm Corp > EV / EBITDA (ltm)

Nymox Pharm Corp EV / EBITDA (ltm) Chart (NYMX)

Nymox Pharm Corp annual/quarterly EV / EBITDA (ltm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Nymox Pharm Corp Market Cap for the quarter ending March 03, 2018 was $242m a 8.27% increase of 20m year over year
  • Nymox Pharm Corp Price / Book for the quarter ending March 03, 2009 was 45.93 a -21.12% decrease of -9.70 year over year
  • Nymox Pharm Corp Enterprise Value for the quarter ending March 03, 2018 was $241m a 8.22% increase of 20m year over year
View Chart On Koyfin